Information Library

Results for: Market Access Implementation

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Reinventing Biopharma

    White Paper — February 1, 2012
    The biopharmaceutical industry today is facing a multifaceted “value challenge.”

  • Franchise Influence and Leverage Mapping

    Brochure — November 10, 2011
    In this industry it’s not just whom you know, but who knows you and how far their sphere of influence reaches.

  • Quintiles Acquires VCG & Associates and VCG Bio

    Press Release — October 19, 2011 – The acquisition of VCG & Associates and VCG BIO strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.

  • How Informative is Your Segmentation?

    Hear from the Experts — September 15, 2011
    Article published by Quintiles' Pieter Sheth-Voss in the Winter 2010 issue of Market Research magazine was recently awarded the David K. Hardin Memorial Award for 2011.

  • Executive Vision Forum 2010: Convergence of Stakeholders

    Presentation — July 9, 2010
    A Holistic Approach to Patient Outcomes - Brian Sweet, CPO, WellPoint. Presentation about the convergence of stakeholders.

  • Executive Vision Forum 2010: Clinical and Commercial Convergence

    Presentation — July 8, 2010
    Pasquale Cetera, VP Portfolio Management, Merck, presentation about the convergence of Clinical and Commercial.

  • Defining Value

    Brochure — June 8, 2010
    Market Access, one of the many Consulting services available from Quintiles, stands ready to help you navigate the value substantiation process, from developing and demonstrating your product’s value platform to winning a preferred position on payer formularies and negotiating pricing and reimbursement contracts.

  • Vital Insights

    Case Study — June 8, 2010
    Quintiles conducted an exhaustive analysis into global and U.S. responses to the use of comparative effectiveness research, identifying key signals to help the customer recognize risk scenarios.

  • Bridging Cultures

    Case Study — May 9, 2010
    Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise.

  • PharmAsia News Article Reprint

    Media Coverage — March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

Page 1 of 1 (10 results)

Subscribe to Email Based on Your Interests

Set preferences